Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Diethyldithiocarbamate-copper complex (CuET) inhibits colorectal cancer progression via miR-16-5p and 15b-5p/ALDH1A3/PKM2 axis-mediated aerobic glycolysis pathway

8 Jan 2021

Abstract excerpt

Exploring novel anticancer drugs to optimize the efficacy may provide a benefit for the treatment of colorectal cancer (CRC). Disulfiram (DSF), as an antialcoholism drug, is metabolized into diethyldithiocarbamate-copper complex (CuET) in vivo, which has been reported to exert the anticancer effects on various tumors in preclinical studies. However, little is known about whether CuET plays an anti-cancer role in...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Autophagy in Disease and Therapy
Share to Cancer, Hypoxia, and Metabolism
Share to Cancer-related molecular mechanisms research

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 33419984
DOI: 10.1038/s41389-020-00295-7

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 10 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Diethyldithiocarbamate-copper complex (CuET) inhibits colorectal cancer progression via miR-16-5p and 15b-5p/ALDH1A3/PKM2 axis-mediated aerobic glycolysis pathwayPMID 33419984Read ↗

Causal association between metabolites and upper gastrointestinal tumors: A Mendelian randomization study.Semantic proximity Read ↗

FTO promotes colorectal cancer progression and chemotherapy resistance via demethylating G6PD/PARP1Semantic proximity Read ↗

Exosomal IDH1 increases the resistance of colorectal cancer cells to 5-FluorouracilSemantic proximity Read ↗

Identification of a Disulfidptosis-Related Gene Signature for Prognostic Implication in Colon AdenocarcinomaSemantic proximity Read ↗

Steroid hormone biosynthesis pathway indicates platinum chemoresistance: Insights From Genomics and MetabolomicsSemantic proximity Read ↗

G9a/GLP inhibitor UNC0642 induces growth arrest in colorectal cancer via induction of ROS generation, coordinated overexpression of GADD genes, and the JNK/p38 MAPK pathwaySemantic proximity Read ↗

Glucose Restriction Combined with Autophagy Inhibition and Chemotherapy in HCT 116 Spheroids Decreases Cell Clonogenicity and Viability Regulated by Tumor Suppressor GenesSemantic proximity Read ↗

Colon Cancer Cells Gene Expression Signature As Response to 5- Fluorouracil, Oxaliplatin, and Folinic Acid TreatmentSemantic proximity Read ↗

SIRT3-IDH2 axis is a target of dietary fructose: implication of IDH2 as a key player in dietary carcinogen toxicity in mice colonSemantic proximity Read ↗

A novel CPT1A covalent inhibitor modulates fatty acid oxidation and CPT1A-VDAC1 axis with therapeutic potential for colorectal cancerSemantic proximity Read ↗

Hepatic Premalignant Alterations Triggered by Human Nephrotoxin Aristolochic Acid I in CaninesSemantic proximity Read ↗

MYG1 drives glycolysis and colorectal cancer development through nuclear-mitochondrial collaborationSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.